Raymond James analyst Dan Wewer downgraded the following stocks from Strong Buy to Outperform:
- Big Lots, Inc. (NYSE: BIG), with a price target cut from $60 to $48;
- Dollar General Corp. (NYSE: DG), with a price target cut from $110 to $105; and
- Dollar Tree, Inc. (NASDAQ: DLTR).
The downgrades were based on a comparative study of branded consumer goods.
“Our latest survey provides evidence that Walmart is reinvesting some of its tax savings into pricing as part of an effort to grow market share,” Wewer said in a Monday note. (See the analyst's track record here.)
Walmart’s prices had previously been in line with Dollar General, but since February, it’s cut the value of traffic-generating products to create a 4.4-percent gap in the companies’ baskets, the analyst said.
Big Lots, meanwhile, closed in on Walmart with a mere 1.9-percent cost disparity. Pricing initiatives in Big Lots' food segment helped it achieve the second least-expensive basket in Raymond James’ survey.
“Although Walmart’s aforementioned price gap is not yet alarming relative to Dollar General and Family Dollar, it does increase the risk for the value retailers,” Wewer said.
Competitors are challenged to protect market share with margin-eating price cuts or protect margins while conceding comps. The problem compounds a hike in milk and egg prices.
Notably, Wewer remains bullish on Big Lots, Dollar General and Dollar Tree, as valuations are lingering below historical averages and the companies continue to beat drugstores in cost. Dollar General’s prices are 34 percent below those of CVS Health Corp (NYSE: CVS) and 29 percent below Walgreens Boots Alliance Inc (NASDAQ: WBA), he said.
At the time of publication, Dollar Tree was up slightly at $97.25, Dollar General was up 0.22 percent at $96.49 and Big Lots down was up 1.62 percent at $42.71.
Wells Fargo Calls A Peak In Discount Retail, Downgrades TJ Maxx's Parent Co.
3 Reasons Why Big Lots Is Off Oppenheimer's Shopping List
Latest Ratings for WMT
|Feb 2018||Credit Suisse||Initiates Coverage On||Neutral|
|Feb 2018||Morgan Stanley||Maintains||Equal-Weight||Equal-Weight|
View More Analyst Ratings for WMT
View the Latest Analyst Ratings
See more from Benzinga
- 'It Could Be In Walmart's Best Interest To Act': Morgan Stanley Breaks Down Pros, Cons Of A Humana Deal
© 2018 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.